TORONTO, Aug. 14, 2025 (GLOBE NEWSWIRE) — Profound Medical Corp. (NASDAQ:PROF; TSX:PRN) (“Profound” or the “Company”), a commercial-stage medical device company that develops and markets customizable, AI-powered, incision-free therapies for the ablation of diseased tissue, today reported unaudited financial results for the second quarter ended June 30, 2025. Unless specified otherwise, all amounts in this press release are expressed in U.S. dollars and are presented in accordance with U.S. generally accepted accounting principles (U.S. GAAP). Business HighlightsUtilization of current TULSA-PRO® systems continues to grow, with “same store” procedure volumes up 10% sequentially from Q1-2025.The Company’s TULSA-PRO® qualified sales pipeline is also growing, and now stands at 80 new systems being classified within one of the “Verify,...

FREDERICK, Md., Aug. 14, 2025 (GLOBE NEWSWIRE) — TOMI Environmental Solutions, Inc. (NASDAQ: TOMZ), a global provider of disinfection and decontamination essentials through its premier Binary Ionization Technology® (BIT™) platform, today announced financial results for the quarter ended June 30, 2025, and provided an update on strategic initiatives designed to drive long-term growth. Q2 2025 Highlights:Service & Training Growth: Service and training revenue increased year-over-year in both the quarter (33%) and first half of 2025 (46%), reflecting growing demand for high-value decontamination services. Strong Gross Margins: Gross profit margin remained healthy at 66% in Q2, underscoring the efficiency of operations and the value of the Company’s technology. Operational Efficiencies: Reduced selling, research, and...

DENVER, Aug. 14, 2025 (GLOBE NEWSWIRE) — authID® (Nasdaq: AUID) (“authID” or the “Company”), a leading provider of biometric identity verification and authentication solutions, today reported financial and operating results for the second quarter ended June 30, 2025. Second Quarter 2025 vs. Second Quarter 2024 Financial SummaryTotal revenue for the quarter increased significantly to a record $1.4 million, compared to $0.3 million a year ago.Operating expenses were $5.9 million, compared to $3.6 million a year ago.Net loss was $4.5 million, or $0.33 per share, compared to a loss of $3.3 million, or $0.34 per share a year ago.Adjusted EBITDA Loss of $3.4 million (non-GAAP measure as defined below), compared with $2.5 million a year ago.Gross bARR (Booked Annual Recurring Revenue) of $2.2 million (non-GAAP measure as defined...

TORONTO, Aug. 14, 2025 (GLOBE NEWSWIRE) — Venus Concept Inc. (“Venus Concept” or the “Company”) (NASDAQ: VERO), a global medical aesthetic technology leader, announced financial results for the three and six months ended June 30, 2025. Summary of Financial Results & Recent Progress:Total revenue for the second quarter of $15.7 million, down 5% year-over-year and up 15% quarter-over-quarterU.S. revenue up $0.4 million, or 5%, year-over-year driven by growth in cash systems sales of $1.0 million, or 23%, year-over-yearSecond quarter GAAP net loss of $11.7 million, compared to $19.9 million last year Second quarter Adjusted EBITDA loss of $8.8 million, compared to $4.1 million last year On April 10, 2025, the Company announced the closing of a registered direct offering priced at-the-market under Nasdaq rules for the...

Second Quarter Net Sales and Adjusted EBITDA Above Guidance Driven by 51% OEM GrowthPreferred Stock Exchange and Public Offering Strengthen Financial PositionGuides to Third Quarter Net Sales of Approximately $15.9 Million Second Quarter 2025 Financial Highlights (All comparisons made are against the prior-year period)Net sales were $16.2 million, compared to $13.2 million, up 23.0%. OEM net sales were $10.1 million, compared to $6.7 million, up 50.6% Gross Margin was 28.3%, compared to 24.0%, up 430 basis points. Net Loss was $(7.0) million, compared to $(13.6) million. Adjusted EBITDA was $(2.2) million, compared to $(6.2) million.RENO, Nev., Aug. 14, 2025 (GLOBE NEWSWIRE) — Dragonfly Energy Holdings Corp. (“Dragonfly Energy” or the “Company”) (Nasdaq: DFLI), an industry leader in energy storage and battery technology, today...

Next-generation claudin 18.2 ISAC BDC-4182 now in Phase 1 dose-escalation study Cash balance of $48.5 million as of June 30, 2025 anticipated to fund key milestones through mid-2026REDWOOD CITY, Calif., Aug. 14, 2025 (GLOBE NEWSWIRE) — Bolt Biotherapeutics (Nasdaq: BOLT), a clinical-stage biopharmaceutical company developing novel immunotherapies for the treatment of cancer, today reported financial results for the second quarter ended June 30, 2025, and provided a business update. “In the second quarter we focused on advancing BDC-4182, the first next-generation Boltbody™ ISAC in our pipeline,” said Willie Quinn, President and Chief Executive Officer. “We are now conducting a Phase 1 dose-escalation study for patients with gastric and gastroesophageal cancer in Australia, and will expand to other countries in the second...

Fortress subsidiary Checkpoint Therapeutics acquired by Sun Pharma; Fortress received ~$28 million at closing and is eligible to receive up to an additional $4.8 million under a contingent value right (CVR), plus a 2.5% royalty on future net sales of UNLOXCYT™ (cosibelimab-ipdl) FDA accepted New Drug Application filing for priority review of CUTX-101 to treat Menkes disease; PDUFA goal date of September 30, 2025 Emrosi™ commercial launch initiated for the treatment of inflammatory lesions of rosacea in adults MIAMI, Aug. 14, 2025 (GLOBE NEWSWIRE) — Fortress Biotech, Inc. (Nasdaq: FBIO) (“Fortress”), an innovative biopharmaceutical company focused on acquiring and advancing assets to enhance long-term value for shareholders through product revenue, equity holdings and dividend and royalty revenue, today announced financial...

IRVINE, Ca., Aug. 14, 2025 (GLOBE NEWSWIRE) — Shimmick Corp. (NASDAQ: SHIM), a leading infrastructure solutions provider in water, climate resilience, energy transition and sustainable transportation, today announced financial results for the second quarter ended July 4, 2025. Second Quarter 2025 and Recent HighlightsReported revenue of $128 million, up 42% year over year, with $113 million coming from Shimmick Projects Reported gross margin of $8 million, as compared to gross margin of $(31) million during the second quarter of 2024, favorable 126% year over year Strong performance on Shimmick Projects contributed gross margin of $15 million, with Non-Core gross margin of $(7) million Reported selling, general and administrative expenses of $15 million, down 20% from the second quarter of 2024 as a result of the continued implementation...

WILMINGTON, Del., Aug. 14, 2025 (GLOBE NEWSWIRE) — Onfolio Holdings Inc. (NASDAQ: ONFO, ONFOW) (OTC: ONFOP) (“Onfolio” or the “Company”), a company that acquires and manages a portfolio of digital marketing and online education businesses, announces financial results for the first quarter ended June 30, 2025. Financial HighlightsSecond quarter revenue for fiscal 2025 increased 82.5% to $3.14M vs. $1.72M for the same period in the prior year and increased 11.7% from $2.81M in Q1 of 2025 Second quarter gross profit for fiscal 2025 increased 98.9% to $1.93M vs. $0.97M for the same period in the prior year and increased 13.5% from $1.7M in Q1 of 2025 Second quarter total operating expenses for fiscal 2025 increased 54.4% to $2.44M vs. $1.58M for the same period in the prior year but decreased 2% from $2.49M...

Attached is an announcement, investor presentation and financial summary of SKEL for the first half of 2025. An open presentation will be held on 15 August, 08:30 am, at Parliament Hotel, Þorvaldsstræti 2-6, 101 Reykjavík (entrance via the old Nasa building). At the meeting, Ásgeir Helgi Reykfjörð Gylfason, CEO, and Magnús Ingi Einarsson, CFO, will present the results and highlights of the Company’s operations. For further information, please contact Ásgeir Helgi Reykfjörð Gylfason, fjarfestar@skel.is.AttachmentsSKEL Announcement 1H 2025SKEL Investor Presentation H1 2025SKEL Financial Summary 30.6.2025